We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Andrew D.C. LaFrence, CPA has been appointed senior vice president and chief financial officer, effective May 29, of Biothera Pharmaceuticals, a clinical stage immuno-oncology company.